Aclaris Therapeutics, Inc. (ACRS): Price and Financial Metrics


Aclaris Therapeutics, Inc. (ACRS)

Today's Latest Price: $3.82 USD

0.00 (0.00%)

Updated Oct 29 1:40pm

Add ACRS to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 240 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

ACRS Stock Summary

  • ACRS's price/sales ratio is 29.51; that's higher than the P/S ratio of 94.24% of US stocks.
  • With a year-over-year growth in debt of -63.83%, Aclaris Therapeutics Inc's debt growth rate surpasses merely 3.75% of about US stocks.
  • As for revenue growth, note that ACRS's revenue has grown -65.86% over the past 12 months; that beats the revenue growth of just 2.71% of US companies in our set.
  • Stocks that are quantitatively similar to ACRS, based on their financial statements, market capitalization, and price volatility, are RESN, CUE, ZYME, IONS, and CLLS.
  • ACRS's SEC filings can be seen here. And to visit Aclaris Therapeutics Inc's official web site, go to www.aclaristx.com.

ACRS Stock Price Chart Interactive Chart >

Price chart for ACRS

ACRS Price/Volume Stats

Current price $3.82 52-week high $5.04
Prev. close $3.82 52-week low $0.70
Day low $3.76 Volume 75,911
Day high $3.84 Avg. volume 599,927
50-day MA $3.05 Dividend yield N/A
200-day MA $1.88 Market Cap 163.20M

Aclaris Therapeutics, Inc. (ACRS) Company Bio


Aclaris Therapeutics, Inc. is a clinical-stage specialty pharmaceutical company focused on identifying, developing, and commercializing novel drugs to address unmet needs in dermatology. The company was founded in 2012 and is based in Malvern, Pennsylvania.


ACRS Latest News Stream


Event/Time News Detail
Loading, please wait...

ACRS Latest Social Stream


Loading social stream, please wait...

View Full ACRS Social Stream

Latest ACRS News From Around the Web

Below are the latest news stories about Aclaris Therapeutics Inc that investors may wish to consider to help them evaluate ACRS as an investment opportunity.

Aclaris Therapeutics (ACRS) Investor Presentation - Slideshow

The following slide deck was published by Aclaris Therapeutics, Inc. in conjunction with this event....

SA Transcripts on Seeking Alpha | September 17, 2020

Aclaris Therapeutics to Present at Upcoming Investor Conferences

WAYNE, Pa., Sept. 01, 2020 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on…

GlobeNewswire | September 1, 2020

Aclaris Therapeutics Reports Second Quarter 2020 Financial Results and Provides R&D and Business Highlights

• First Subject Dosed in Phase 2a Trial of ATI-450, an Investigational Oral MK2 Inhibitor, as a Potential Treatment for Moderate to Severe Rheumatoid …

Benzinga | August 7, 2020

Will Aclaris Therapeutics (ACRS) Report Negative Q2 Earnings? What You Should Know

Aclaris (ACRS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Yahoo Finance | August 6, 2020

Seborrhea Pipeline Research Monitor, 2020 Featuring Aclaris Therapeutics, Arcutis Biotherapeutics, Cutanea Life Sciences, and Vyome Therapeutics - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Seborrhea Pipeline Research Monitor, 2020 - Drugs, Companies, Clinical Trials, R&D Pipeline Updates, Status and Outlook" report has been added to ResearchAndMarkets.com's offering. PIPELINE HIGHLIGHTS Seborrhea is one of the widely researched conditions during 2020 with 4 companies actively focusing on realizing pipeline's potential. Development of Seborrhea medicines is identified as integral to the strategy of the majority of companies operating in the indust

Business Wire | July 24, 2020

Read More 'ACRS' Stories Here

ACRS Price Returns

1-mo 49.22%
3-mo 77.67%
6-mo 208.06%
1-year 107.61%
3-year -84.85%
5-year -73.60%
YTD 102.12%
2019 -74.42%
2018 -70.03%
2017 -9.14%
2016 0.74%
2015 N/A

Continue Researching ACRS

Want to see what other sources are saying about Aclaris Therapeutics Inc's financials and stock price? Try the links below:

Aclaris Therapeutics Inc (ACRS) Stock Price | Nasdaq
Aclaris Therapeutics Inc (ACRS) Stock Quote, History and News - Yahoo Finance
Aclaris Therapeutics Inc (ACRS) Stock Price and Basic Information | MarketWatch


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.8427 seconds.